Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy
The American Journal of Medicine
|June 1, 1986
Abstract:
Splenectomy has been the traditional initial treatment for hairy cell leukemia, with medical treatment reserved for resistant disease. This report describes two patients treated with recombinant alpha-2 interferon without prior splenectomy. Both patients responded well to interferon therapy. Alpha-2 interferon may become the initial therapy of choice for hairy cell leukemia.


